These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 30950912)

  • 1. PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics.
    Stevens T; Sangkuhl K; Brown JT; Altman RB; Klein TE
    Pharmacogenet Genomics; 2019 Aug; 29(6):136-154. PubMed ID: 30950912
    [No Abstract]   [Full Text] [Related]  

  • 2. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
    Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention-deficit/hyperactivity disorder: current aspects on pharmacogenetics.
    Rohde LA; Roman T; Hutz MH
    Pharmacogenomics J; 2003; 3(1):11-3. PubMed ID: 12629578
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.
    Contini V; Rovaris DL; Victor MM; Grevet EH; Rohde LA; Bau CH
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):555-60. PubMed ID: 22709890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics.
    Polanczyk G; Zeni C; Genro JP; Roman T; Hutz MH; Rohde LA
    Pharmacogenomics; 2005 Apr; 6(3):225-34. PubMed ID: 16013954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
    Kim BN; Kim JW; Cummins TD; Bellgrove MA; Hawi Z; Hong SB; Yang YH; Kim HJ; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
    J Clin Psychopharmacol; 2013 Jun; 33(3):356-62. PubMed ID: 23609393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective.
    Rovaris DL; Mota NR; da Silva BS; Girardi P; Victor MM; Grevet EH; Bau CH; Contini V
    Pharmacogenomics; 2014 Jul; 15(10):1365-81. PubMed ID: 25155937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention deficit hyperactivity disorder pharmacogenetics: the dopamine transporter and D4 receptor.
    McGough JJ
    Pharmacogenomics; 2012 Mar; 13(4):365-8. PubMed ID: 22379991
    [No Abstract]   [Full Text] [Related]  

  • 9. A current update on ADHD pharmacogenomics.
    Kieling C; Genro JP; Hutz MH; Rohde LA
    Pharmacogenomics; 2010 Mar; 11(3):407-19. PubMed ID: 20235795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What do dopamine transporter and catechol-o-methyltransferase tell us about attention deficit-hyperactivity disorder? Pharmacogenomic implications.
    Levy F
    Aust N Z J Psychiatry; 2007 Jan; 41(1):10-6. PubMed ID: 17464676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Response With Methylphenidate to ADHD-Like Symptoms in Pervasive Developmental Disorder: Does CES-1 Enzyme Gene Polymorphism Have a Role?].
    Akyol Ardıç Ü; Ercan ES; Aygüneş D; Yüce D; Durak S; Kosova B
    Turk Psikiyatri Derg; 2017; 28(2):89-94. PubMed ID: 29192941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of dopamine transporter knockout mice as an animal model of AD/HD].
    Kasahara Y; Kubo Y; Sora I
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):185-9. PubMed ID: 25069256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pharmacokinetics and Pharmacogenomics of Psychostimulants.
    Markowitz JS; Melchert PW
    Child Adolesc Psychiatr Clin N Am; 2022 Jul; 31(3):393-416. PubMed ID: 35697392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder.
    Srinivas NR; Hubbard JW; Quinn D; Midha KK
    Clin Pharmacol Ther; 1992 Nov; 52(5):561-8. PubMed ID: 1424430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Methylphenidate Response in ADHD Using Machine Learning Approaches.
    Kim JW; Sharma V; Ryan ND
    Int J Neuropsychopharmacol; 2015 May; 18(11):pyv052. PubMed ID: 25964505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of human CES1 genetic variation on enzyme activity assessed by ritalinic acid/methylphenidate ratios.
    Stage C; Dalhoff K; Rasmussen HB; Schow Guski L; Thomsen R; Bjerre D; Ferrero-Miliani L; Busk Madsen M; Jürgens G
    Basic Clin Pharmacol Toxicol; 2019 Jul; 125(1):54-61. PubMed ID: 30801959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric pharmacogenetics: personalizing psychostimulant therapy in attention-deficit/hyperactivity disorder.
    Masellis M; Basile VS; Muglia P; Ozdemir V; Macciardi FM; Kennedy JL
    Behav Brain Res; 2002 Mar; 130(1-2):85-90. PubMed ID: 11864722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
    Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
    Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate side effect profile is influenced by genetic variation in the attention-deficit/hyperactivity disorder-associated CES1 gene.
    Johnson KA; Barry E; Lambert D; Fitzgerald M; McNicholas F; Kirley A; Gill M; Bellgrove MA; Hawi Z
    J Child Adolesc Psychopharmacol; 2013 Dec; 23(10):655-64. PubMed ID: 24350812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.
    Pagerols M; Richarte V; Sánchez-Mora C; Garcia-Martínez I; Corrales M; Corominas M; Cormand B; Casas M; Ribasés M; Ramos-Quiroga JA
    Pharmacogenomics J; 2017 Jan; 17(1):98-104. PubMed ID: 26810137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.